SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-10-004177
Filing Date
2010-01-21
Accepted
2010-01-21 21:02:01
Documents
1
Period of Report
2010-01-19

Document Format Files

Seq Description Document Type Size
1 1/19/2010 OPTION GRANT rrd263378.html 4  
1 1/19/2010 OPTION GRANT rrd263378.xml 4 5630
  Complete submission text file 0001181431-10-004177.txt   7448
Mailing Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277
Business Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277 704-341-1516
Chelsea Therapeutics International, Ltd. (Issuer) CIK: 0001333763 (see all company filings)

IRS No.: 203174202 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 175 CASSIA WAY, SUITE 115 HENDERSON NV 89014
Business Address
Rueckert William Dodge (Reporting) CIK: 0001380016 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51462 | Film No.: 10539976